Jay S Naik - Department of Surgery, Leicester University

基本信息

浏览量：36

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 151 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Acid-Sensing Ion Channel 1a Deficiency Drives Endocrine Hypertension in Male Mice

Selina M Garcia, Megan N Tuineau, Xavier A DeLeon,Neil D Detweiler, Shristey Tamang,Nancy L Kanagy,Laura V Gonzalez Bosc,Thomas C Resta,Jay S Naik,Nikki L Jernigan

bioRxiv the preprint server for biology (2025)

引用0浏览0WOS引用

Aligning Patient Values and Code Status: Choice of Diction's Effect (CODE) Study

Karthik J. Kota,Catherine Chen, Renu George, Samantha Nagengast, Andrew Azab,Raman Bhalla,Payal Dave,Stephanie Ji, Ibiyonu Lawrence,Jay Naik, Sofiul Noman,Payal Parikh,Manish Patel,Sheetal Patel, Stephen O. Priest, James Prister,Daniel Schaer, Christina Theodorou Ross,Rohan V. Shah,Paul Duberstein,Michael B. Steinberg

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY（2024）

引用0浏览0WOS引用

POSTER SESSION A: ACCEPTANCE AND COMMITMENT THERAPY FOR MEDICATION DECISION-MAKING AND QUALITY OF LIFE IN BREAST CANCER: A RANDOMIZED PILOT TRIAL

Christopher D. Graham,Rachel Ellison,Louise H. Hall,Jane Clark,Sophie M. C. Green,Emma McNaught,Hollie Wilkes, Gita Robson, Ian Lorentz, Lucy Holmes, Nicky Bould,Suzanne Hartley,Jay Naik, Sarah Buckley, Charlotte Hirst,Sue Hartup,Richard Neal,Galina I. Velikova,Amanda Farrin,Michelle Collinson,Samuel G. Smith

ANNALS OF BEHAVIORAL MEDICINE (2024): S19-S19

引用0浏览0引用

Supplemental File 4_Vsmc_all_lgvsmall.csv

Jacob R. Anderson,Emily E. Morin,Kathryn J. Brayer,Laura V. González Bosc, Nancy L. Kanagy,Jay Naik

Figshare (2023)

引用0浏览0引用

CO86 Improving External Validity of Trial Outcomes when Estimating Subgroup QALY Gains: A Case Study of Pembrolizumab±Chemotherapy Vs. Cetuximab+Platinum-Based Chemotherapy (‘EXTREME’) in Squamous Cell Carcinoma of the Head and Neck

A. Bullement,J. Naik,M. Schlichting,C. P. Pescott

Value in Health（2023）

引用0浏览0引用

EE359 Cost-Effectiveness of Pembrolizumab + Chemotherapy Versus Cetuximab-Containing Regimens ‘extreme’ and ‘tpex’, for R/M SCCHN Patients with a CPS Between 1 and 19, in Italy

P. Ivanyi,A. Bullement, A. Ciccarone,M. Schlichting,J. Naik,G.L. Colombo,A. Gandola,C.P. Pescott

Value in Healthno. 12 (2023): S120-S120

引用0浏览0引用

Endothelial Cell Heterogeneity Between Conduit and Resistance Mesenteric Arteries

Jacob R. Anderson,Emily E. Morin,Kathryn J. Brayer,Sophia Salbato,Laura V. Gonzalez Bosc,Nancy L. Kanagy,Jay S. Naik

Physiological Genomics（2023）

引用1浏览0WOS引用

Quality-adjusted Life-Year and Life-Year Estimates for Patients with Recurrent/metastatic Squamous Cell Carcinoma of the Head and Neck in the Combined Positive Score 1-19 Subgroup Treated with Pembrolizumab Plus /- Chemotherapy Vs Cetuximab-Containing Regimens

P. Ivanyi,A. Bullement,M. Schlichting,J. Naik,C. P. Pescott

ANNALS OF ONCOLOGY (2023): S1609-S1609

引用0浏览0引用

358MO Quality-adjusted Life-Year and Life-Year Estimates for Patients with Recurrent/metastatic Squamous Cell Carcinoma of the Head and Neck in the Combined Positive Score 1-19 Subgroup Treated with Pembrolizumab +/- Chemotherapy Vs Cetuximab-Containing Regimens

P. Ivanyi,A. Bullement,M. Schlichting,J. Naik,C.P. Pescott

Annals of Oncology（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn